Cellosaurus PFIZi004-A (CVCL_9S34)
| Cell line name | PFIZi004-A |
|---|---|
| Synonyms | EM2-7F |
| Accession | CVCL_9S34 |
| Resource Identification Initiative | To cite this cell line use: PFIZi004-A (RRID:CVCL_9S34) |
| Comments | From: Pfizer, Inc.; New York; USA. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
| Sequence variations |
|
| Disease | Erythromelalgia (NCIt: C34593) Primary erythromelalgia (ORDO: Orphanet_90026) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Originate from same individual | CVCL_9S33 ! PFIZi003-A |
| Sex of cell | Male |
| Age at sampling | 4Y |
| Category | Induced pluripotent stem cell |
| Publications | PubMed=27099175; DOI=10.1126/scitranslmed.aad7653 |
| Cross-references | |
| Cell line databases/resources | hPSCreg; PFIZi004-A
SKIP; SKIP002633 |
| Encyclopedic resources | Wikidata; Q54947257 |
| Entry history | |
| Entry creation | 23-Feb-2016 |
| Last entry update | 19-Dec-2024 |
| Version number | 10 |